RNA-guided nucleases provide a strategy for killing specific bacterial species in complex populations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Citorik, R., Mimee, M. & Lu, T. Nat. Biotechnol. 32, 1141–1145 (2014).
Bikard, D. et al. Nat. Biotechnol. 32, 1146–1150 (2014).
Jinek, M. et al. Science 337, 816–821 (2012).
Gomaa, A.A. et al. MBio 5, e00928-13.
Silver, L.L. Clin. Microbiol. Rev. 24, 71–109 (2011).
The Pew Charitable Trusts. Antibiotics Currently in Clinical Development http://www.pewtrusts.org/en/multimedia/data-visualizations/2014/antibiotics-currently-in-clinical-development (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Silver, L. Antibacterials for any target. Nat Biotechnol 32, 1102–1104 (2014). https://doi.org/10.1038/nbt.3060
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3060
This article is cited by
-
Accelerating innovation in rapid diagnostics and targeted antibacterials
Nature Biotechnology (2015)